Search alternatives:
significant challenge » significant changes (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
better decrease » teer decrease (Expand Search), between decreased (Expand Search)
Showing 41 - 60 results of 13,393 for search '(( significantly ((better decrease) OR (greater decrease)) ) OR ( significant challenge decrease ))', query time: 0.40s Refine Results
  1. 41
    Blood biochemistry of different dietary groups at the end of the growth experiment and after bacterial challenge.

    Blood biochemistry of different dietary groups at the end of the growth experiment and after bacterial challenge. by Razia Liaqat (17873634)

    Published 2024
    Save to List
    Saved in:
  2. 42
    Hematology from different dietary groups at the end of the growth experiment and after bacterial challenge.

    Hematology from different dietary groups at the end of the growth experiment and after bacterial challenge. by Razia Liaqat (17873634)

    Published 2024
    Save to List
    Saved in:
  3. 43
    Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression in ND-75<sup>KD</sup> flies.

    Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)

    Published 2023
    Save to List
    Saved in:
  4. 44
    Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores.

    Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 45
    A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70).

    A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 46
    Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as median with interquartile ranges.

    Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 47
    The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0).

    The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 48
    Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mean ± standard deviation (SD) for normally distributed variables and median with interquartile ranges for non-normally distributed.

    Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 49
    Tricuspid regurgitation pressure gradient of all 17 dogs.

    Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 50
    Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups.

    Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 51
    Sobel test for the significance of the mediation effect.

    Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

    Published 2024
    Save to List
    Saved in:
  12. 52
    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 53
    Projections of incidence for hematological malignancies in mainland China.

    Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 54
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 55
    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 56
    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 57
    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    The raw data used in this study.

    The raw data used in this study. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Projections of mortality for hematological malignancies in mainland China.

    Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: